질병관리청의 데이터를 이용한 COVID-19 확진자의 사망에 대한 영향요인과 혈액변수의 타당도
Impact Factors and Validity of Blood Variables on Death in COVID-19 patient: Using Data of Korea Disease Control and Prevention Agency
1
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
본 연구에서 우리는 COVID-19의 사망에 대한 영향요인과 혈액변수의 타당도를 제안하였다. 이연구를 위하여 질병관리본부 중앙방역대책본부에서 제공하는 2020년 4월 30일까지 격리해제되었거나 사망한 COVID-19확진자 5628명의 임상역학정보를 활용하였으며, 자료는 R 3.4.1을 사용하여분석하였다. 분석결과, 사망에 대한 위험요인으로 치매(HR 7.03), 많은 나이(HR 5.39), 높은 림프구(HR 4.66), 암(HR 4.27), 호흡곤란(HR 3.25), 만성폐쇄성 폐질환(HR 3.22), 의식변화(HR 3.13), 심장질환(HR 2.24), 높은 혈소판(HR 2.14), 비정상 이완기 혈압(HR 2.02), 열(HR 1.69)이 확인되었다. 사망에 대한 혈액검사의 타당도는 림프구, 헤모글로빈, 헤마토크리트, 혈소판, 백혈구 순으로 정확도가 높았다. 그러므로 COVID-19 환자를 치료할 때 사망의 위험요인으로 확인된 초기 임상적 특징및 기저질환, 혈액검사의 소견을 고려하여 보다 효율적인 관리가 가능하도록 해야 할 것이다.
Abstract
In this paper, we propose impact factors and validity of blood variables on death of COVID-19 patients. The clinical-epidemiological data of 5628 COVID-19 patients, provided from Korea Disease Control and Prevention Agency as day of 30th April 2020, were used. As results, impact factors of death were dementia, older age, high lymphocyte, cancer, dyspnea, COPD, change of consciousness, heart disease, high platelets, abnormal diastolic pressure and fever. The validities of blood variables for death were high in the order of lymphocyte, hemoglobin, hematocrit, platelet and WBC. Therefore, risk factors such as initial clinical characteristics, underlying disease and blood test results, could be regarded for efficient management of COVID-19 patients.
참고문헌 (18)
- Cécile Viboud, "Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a Smoldering Pandemic", The Journal of Infectious Diseases, 192(2), pp.233~248 (2005), Oxford University Press (OUP)[DOI]
- L. Simonsen, "Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution", Journal of Infectious Diseases, 178(1), pp.53~60 (1998), Oxford University Press (OUP)[DOI]
- Suresh Rewar, "Treatment and Prevention of Pandemic H1N1 Influenza", Annals of Global Health, 81(5), pp.645~ (2018), Ubiquity Press, Ltd.[DOI]
- "Korean Ministry of Health and Welfare" (2020)[URL]
- "Coronaboard" (2020)[URL]
- "World Coronaboard" (2020)[URL]
- A. E. Gorbalenya, "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2", Nature Microbiology, 5(4), pp.536~544 (2020), Springer Science and Business Media LLC[DOI]
- A. Giacomelli, "Self-reported olfactory and taste disorders in SARSCoV-2 patients: a cross-sectional study", Clinical Infectious Diseases, 71(15), pp.ciaa330~ (2020)[DOI]
- 이승화, "신종 코로나바이러스 감염증(COVID-19) 유행의 대응과 치료", Korean Journal of Family Practice, 10(2), pp.87~95 (2020), 대한가정의학회[DOI]
- Andrea Saglietto, "COVID-19 in Europe: the Italian lesson", The Lancet, 395(10230), pp.1110~1111 (2020), Elsevier BV[DOI]
- Ji Wonjun, "Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study", Journal of Korean Medical Science, 35(25), pp.1~15 (2020), 대한의학회[DOI]
- Nanshan Chen, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", The Lancet, 395(10223), pp.507~513 (2020), Elsevier BV[DOI]
- Wei-jie Guan, "Clinical Characteristics of Coronavirus Disease 2019 in China", New England Journal of Medicine, 382(18), pp.1708~1720 (2020), Massachusetts Medical Society[DOI]
- Dawei Wang, "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020), American Medical Association (AMA)[DOI]
- "Epidemic update and risk assessment of 2019 novel coronavirus" (2020)[URL]
- G. M. Kuster, "SARSCoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?", European Heart Journal, 41(19), pp.ehaa235~ (2020)[DOI]
- Susan R. Weiss, "Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus", Microbiology and Molecular Biology Reviews, 69(4), pp.635~664 (2005), American Society for Microbiology[DOI]
- Nicole R. Sexton, "Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens", Journal of Virology, 90(16), pp.7415~7428 (2016), American Society for Microbiology[DOI]
